Risk of Self-Reported Penicillin Allergy Despite Removal of Penicillin Allergy Label
This secondary analysis of adult patients in the Penicillin Allergy Clinical Decision Rule (PALACE) Study investigates the risk of self-reported penicillin allergy despite removal of penicillin allergy label.
Authors
- Sara Vogrin (ORCID: https://orcid.org/0000-0002-1597-9421)
- Jason A. Trubiano (ORCID: https://orcid.org/0000-0002-5111-6367)
- Abby Douglas (ORCID: https://orcid.org/0000-0002-8314-352X)
- Nicholas Turner (ORCID: https://orcid.org/0000-0003-0650-4894)
- Natasha E. Holmes (ORCID: https://orcid.org/0000-0001-8501-4054)
- Ana Maria Copaescu (ORCID: https://orcid.org/0000-0002-9183-5032)
- Elizabeth J. P. Phillips
Institutions
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- McGill University Health Centre (CA)
- St Vincent's Hospital Melbourne (AU)
- Peter Doherty Institute (AU)
- Duke Medical Center (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.29621
- Citations
- 5
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.24
Funders
- AstraZeneca
- Gilead Sciences
- McGill University
- Regeneron Pharmaceuticals
- Austin Medical Research Foundation
- Novavax
- McGill University Health Centre
- BioCryst
- Esperion Therapeutics
- National Institutes of Health
- Centers for Disease Control and Prevention
- Medical Research Council
- National Health and Medical Research Council